Quick Answer
Ascend Wellness Holdings, Inc. reported Cash And Cash Equivalents At Carrying Value of $85.68 million for the year ending 2025.
- Ascend Wellness Holdings, Inc. showed a decrease of -2.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Ascend Wellness Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $62.63 million | Q2 2021: $104.21 million | Q3 2021: $204.51 million | Q1 2022: $143.80 million | Q2 2022: $140.55 million | Q3 2022: $91.39 million | Q1 2023: $73.30 million | Q2 2023: $68.05 million | Q3 2023: $63.92 million | Q1 2024: $72.90 million | Q2 2024: $83.71 million | Q3 2024: $65.28 million | Q1 2025: $100.03 million | Q2 2025: $95.27 million | Q3 2025: $87.27 million.
- Over the full 6 years of available data (2020 to 2025), Ascend Wellness Holdings, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 51.5%.
- Historical annual values: Fiscal year 2025: $85.68 million | Fiscal year 2024: $88.25 million | Fiscal year 2023: $72.51 million | Fiscal year 2022: $74.15 million | Fiscal year 2021: $155.48 million | Fiscal year 2020: $56.55 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: